CN108904739A - A kind of Chinese and Western compound preparation and preparation method thereof for treating senile dementia - Google Patents
A kind of Chinese and Western compound preparation and preparation method thereof for treating senile dementia Download PDFInfo
- Publication number
- CN108904739A CN108904739A CN201811120481.4A CN201811120481A CN108904739A CN 108904739 A CN108904739 A CN 108904739A CN 201811120481 A CN201811120481 A CN 201811120481A CN 108904739 A CN108904739 A CN 108904739A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- senile dementia
- western
- piracetam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese and Western compound preparation and preparation method thereof for treating senile dementia, which is compounded by traditional Chinese medicinal components and western medicine component, and the traditional Chinese medicinal components are prepared by the raw material of following parts by weight:10-20 parts of Rhizoma Gastrodiae, 10-15 parts of Radix Salviae Miltiorrhizae, 10-15 parts of ginkgo leaf, 5-10 parts of cortex albiziae, 5-10 parts of fructus alpiniae oxyphyllae, 2-5 parts of dark plum, 5-10 parts of pheretima;The Western medicine is composed of the following components:1-1.5 parts of piracetam, 1-1.5 parts of Doneppezil Hydrochloride, 0.5-1 parts of vitamin B1.The present invention takes the method that Chinese and Western medicine combines, it can effectively improve cranial nerve, the cerebrovascular and brain blood circulation function, improve and treat insomnia forgetfulness caused by senile dementia, failure of memory, cognitive ability decline etc., short treating period, quick, side effect is low, has wide medical application prospect.
Description
Technical field
The present invention relates to field of medicaments, and in particular to a kind of Chinese and Western compound preparation for treating senile dementia and its preparation side
Method.
Background technique
Senile dementia can be divided into Alzheimer disease (AD), vascular dementia (VD), Mixed dementia (AD+VD) and other
Dementia betides a kind of primary degenerative encephalopathy of Senectitude and presenium, is that a kind of duration higher nerve function is living
Dynamic obstacle is that cognition and memory function constantly deteriorate in clinical manifestation, the decline of activity of daily living progressive, and has various nerves
The symptoms such as mental symptom and behavior disorder.Senile dementia is the relatively high disease of disease incidence, the data sheet of the World Health Organization
Bright, the elderly about 20,000,000 of senile dementia is suffered from the current whole world, it is contemplated that arrives the year two thousand twenty, global patients of senile dementia will
More than 30,000,000 people.Therefore, exploitation improves cognition dysfunction, and the drug for treating senile dementia becomes world community medical treatment work
The research emphasis of author receives the great attention of Chinese and western medical field.
Currently, treatment senile dementia Western medicine have very much, these drugs can only respite patient's recognizing ability decline,
But disease cannot be delayed to develop, and Western medicine has the adverse reactions such as serious liver renal toxicity, and expensive.In recent years, state
Inside and outside experts and scholars begin to focus on natural traditional Chinese medicine, and Chinese medicine has long-term effect strong, and drug resistance is strong, safe and non-toxic advantage, very suitable
It closes patients of senile dementia to take for a long time, but curative effect is not significant, it is therefore desirable to continue to explore and develop new treatment senile dementia
Drug.
Summary of the invention
To solve the above problems, the present invention provides a kind of Chinese and Western compound preparation for treating senile dementia and its preparation sides
Method.
To achieve the above object, the technical scheme adopted by the invention is as follows:
A kind of Chinese and Western compound preparation for treating senile dementia, is compounded by traditional Chinese medicinal components and western medicine component, it is described in
Medicine component is prepared by the raw material of following parts by weight:
10-20 parts of Rhizoma Gastrodiae, 10-15 parts of Radix Salviae Miltiorrhizae, 10-15 parts of ginkgo leaf, 5-10 parts of cortex albiziae, 5-10 parts of fructus alpiniae oxyphyllae, dark plum
2-5 parts, 5-10 parts of pheretima;
The Western medicine is composed of the following components:
1-1.5 parts of piracetam, 1-1.5 parts of Doneppezil Hydrochloride, 0.5-1 parts of vitamin B1.
Preferably, the traditional Chinese medicinal components are prepared by the raw material of following parts by weight:
10 parts of Rhizoma Gastrodiae, 10 parts of Radix Salviae Miltiorrhizae, 10 parts of ginkgo leaf, 5 parts of cortex albiziae, 5 parts of fructus alpiniae oxyphyllae, 2 parts of dark plum, 5 parts of pheretima;
The Western medicine is composed of the following components:
1 part of piracetam, 1 part of Doneppezil Hydrochloride, 1 part of vitamin B1.
Preferably, the traditional Chinese medicinal components are prepared by the raw material of following parts by weight:
20 parts of Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizae, 15 parts of ginkgo leaf, 10 parts of cortex albiziae, 10 parts of fructus alpiniae oxyphyllae, 5 parts of dark plum, 10 parts of pheretima;
The Western medicine is composed of the following components:
1.5 parts of piracetam, Doneppezil Hydrochloride 1.5,1 part of vitamin B1.
Preferably, the traditional Chinese medicinal components are prepared by the raw material of following parts by weight:
15 parts of Rhizoma Gastrodiae, 12.5 parts of Radix Salviae Miltiorrhizae, 12.5 parts of ginkgo leaf, 7.5 parts of cortex albiziae, 7.5 parts of fructus alpiniae oxyphyllae, 3.5 parts of dark plum,
7.5 parts of dragon;
The Western medicine is composed of the following components:
1.25 parts of piracetam, 1.25 parts of Doneppezil Hydrochloride, 0.75 part of vitamin B1.
The present invention also provides a kind of preparation methods of Chinese and Western compound preparation for treating senile dementia, including walk as follows
Suddenly:
S1, each component is weighed by above-mentioned formula;
S2, after cleaning weighed Rhizoma Gastrodiae, Radix Salviae Miltiorrhizae, ginkgo leaf, cortex albiziae, fructus alpiniae oxyphyllae, dark plum, pheretima, it is placed in flash mention
It takes in device, the water of 6-8 times of volume is added, after handling 30-60S, lignin degradation is added for the ratio of 2-3% by mass percentage
Enzyme digests 1-2h at 30-50 DEG C, filters, obtains enzymolysis liquid;
S3, by natural thaw again after resulting enzymolysis liquid quick freeze, precipitate age of starch in extract;Collect supernatant
Liquid, remainder centrifugation are collected centrifugal liquid and are incorporated in supernatant, be spray-dried, obtain powder;
S4, after resulting powder and weighed piracetam, Doneppezil Hydrochloride, vitamin B1 are mixed evenly,
Microwave disinfection, it is encapsulated by 0.2-0.25/ specification, packaging to get.
The invention has the advantages that:
Take the method that Chinese and Western medicine combines, can effectively improve cranial nerve, the cerebrovascular and brain blood circulation function, improve and
Treat insomnia forgetfulness caused by senile dementia, failure of memory, cognitive ability decline etc., short treating period, quick, side effect
It is low, there is wide medical application prospect.
Specific embodiment
The present invention is described in detail combined with specific embodiments below.Following embodiment will be helpful to the technology of this field
Personnel further understand the present invention, but the invention is not limited in any way.It should be pointed out that the ordinary skill of this field
For personnel, without departing from the inventive concept of the premise, various modifications and improvements can be made.These belong to the present invention
Protection scope.
Embodiment 1
A kind of Chinese and Western compound preparation for treating senile dementia, is compounded by traditional Chinese medicinal components and western medicine component, it is described in
Medicine component is prepared by the raw material of following parts by weight:
10 parts of Rhizoma Gastrodiae, 10 parts of Radix Salviae Miltiorrhizae, 10 parts of ginkgo leaf, 5 parts of cortex albiziae, 5 parts of fructus alpiniae oxyphyllae, 2 parts of dark plum, 5 parts of pheretima;
The Western medicine is composed of the following components:
1 part of piracetam, 1 part of Doneppezil Hydrochloride, 1 part of vitamin B1.
Embodiment 2
A kind of Chinese and Western compound preparation for treating senile dementia, is compounded by traditional Chinese medicinal components and western medicine component, it is described in
Medicine component is prepared by the raw material of following parts by weight:
20 parts of Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizae, 15 parts of ginkgo leaf, 10 parts of cortex albiziae, 10 parts of fructus alpiniae oxyphyllae, 5 parts of dark plum, 10 parts of pheretima;
1.5 parts of piracetam, Doneppezil Hydrochloride 1.5,1 part of vitamin B1.
Embodiment 3
A kind of Chinese and Western compound preparation for treating senile dementia, is compounded by traditional Chinese medicinal components and western medicine component, it is described in
Medicine component is prepared by the raw material of following parts by weight:
15 parts of Rhizoma Gastrodiae, 12.5 parts of Radix Salviae Miltiorrhizae, 12.5 parts of ginkgo leaf, 7.5 parts of cortex albiziae, 7.5 parts of fructus alpiniae oxyphyllae, 3.5 parts of dark plum,
7.5 parts of dragon
The Western medicine is composed of the following components:
1.25 parts of piracetam, 1.25 parts of Doneppezil Hydrochloride, 0.75 part of vitamin B1.
Embodiment 4
S1, each component is weighed by formula described in embodiment 1, embodiment 2 or implementation 3;
S2, after cleaning weighed Rhizoma Gastrodiae, Radix Salviae Miltiorrhizae, ginkgo leaf, cortex albiziae, fructus alpiniae oxyphyllae, dark plum, pheretima, it is placed in flash mention
It takes in device, the water of 6-8 times of volume is added, after handling 30-60S, lignin degradation is added for the ratio of 2-3% by mass percentage
Enzyme digests 1-2h at 30-50 DEG C, filters, obtains enzymolysis liquid;
S3, by natural thaw again after resulting enzymolysis liquid quick freeze, precipitate age of starch in extract;Collect supernatant
Liquid, remainder centrifugation are collected centrifugal liquid and are incorporated in supernatant, be spray-dried, obtain powder;
S4, after resulting powder and weighed piracetam, Doneppezil Hydrochloride, vitamin B1 are mixed evenly,
Microwave disinfection, it is encapsulated by 0.2-0.25/ specification, packaging to get.
Specific embodiments of the present invention are described above.It is to be appreciated that the invention is not limited to above-mentioned
Particular implementation, those skilled in the art can make a variety of changes or modify within the scope of the claims, this not shadow
Ring substantive content of the invention.In the absence of conflict, the feature in embodiments herein and embodiment can any phase
Mutually combination.
Claims (5)
1. a kind of Chinese and Western compound preparation for treating senile dementia, is compounded, feature exists by traditional Chinese medicinal components and western medicine component
In:The traditional Chinese medicinal components are prepared by the raw material of following parts by weight:
10-20 parts of Rhizoma Gastrodiae, 10-15 parts of Radix Salviae Miltiorrhizae, 10-15 parts of ginkgo leaf, 5-10 parts of cortex albiziae, 5-10 parts of fructus alpiniae oxyphyllae, dark plum 2-5
Part, 5-10 parts of pheretima;
The Western medicine is composed of the following components:
1-1.5 parts of piracetam, 1-1.5 parts of Doneppezil Hydrochloride, 0.5-1 parts of vitamin B1.
2. a kind of Chinese and Western compound preparation for treating senile dementia as described in claim 1, it is characterised in that:The Chinese medicine group
Divide and is prepared by the raw material of following parts by weight:
10 parts of Rhizoma Gastrodiae, 10 parts of Radix Salviae Miltiorrhizae, 10 parts of ginkgo leaf, 5 parts of cortex albiziae, 5 parts of fructus alpiniae oxyphyllae, 2 parts of dark plum, 5 parts of pheretima;
The Western medicine is composed of the following components:
1 part of piracetam, 1 part of Doneppezil Hydrochloride, 1 part of vitamin B1.
3. a kind of Chinese and Western compound preparation for treating senile dementia as described in claim 1, it is characterised in that:The Chinese medicine group
Divide and is prepared by the raw material of following parts by weight:
20 parts of Rhizoma Gastrodiae, 15 parts of Radix Salviae Miltiorrhizae, 15 parts of ginkgo leaf, 10 parts of cortex albiziae, 10 parts of fructus alpiniae oxyphyllae, 5 parts of dark plum, 10 parts of pheretima;
The Western medicine is composed of the following components:
1.5 parts of piracetam, Doneppezil Hydrochloride 1.5,1 part of vitamin B1.
4. a kind of Chinese and Western compound preparation for treating senile dementia as described in claim 1, it is characterised in that:The Chinese medicine group
Divide and is prepared by the raw material of following parts by weight:
15 parts of Rhizoma Gastrodiae, 12.5 parts of Radix Salviae Miltiorrhizae, 12.5 parts of ginkgo leaf, 7.5 parts of cortex albiziae, 7.5 parts of fructus alpiniae oxyphyllae, 3.5 parts of dark plum, pheretima
7.5 part;
The Western medicine is composed of the following components:
1.25 parts of piracetam, 1.25 parts of Doneppezil Hydrochloride, 0.75 part of vitamin B1.
5. a kind of preparation method for the Chinese and Western compound preparation for treating senile dementia, it is characterised in that:Include the following steps:
S1, each component is weighed by the described in any item formulas of claim 1-4;
S2, after cleaning weighed Rhizoma Gastrodiae, Radix Salviae Miltiorrhizae, ginkgo leaf, cortex albiziae, fructus alpiniae oxyphyllae, dark plum, pheretima, it is placed in flash extracter
It is interior, the water of 6-8 times of volume is added, after handling 30-60S, lignin-degrading enzymes are added for the ratio of 2-3% by mass percentage,
1-2h is digested at 30-50 DEG C, is filtered, is obtained enzymolysis liquid;
S3, by natural thaw again after resulting enzymolysis liquid quick freeze, precipitate age of starch in extract;Supernatant is collected,
Remainder centrifugation is collected centrifugal liquid and is incorporated in supernatant, is spray-dried, obtains powder;
S4, after resulting powder and weighed piracetam, Doneppezil Hydrochloride, vitamin B1 are mixed evenly, microwave
Sterilization, it is encapsulated by 0.2-0.25/ specification, packaging to get.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811120481.4A CN108904739A (en) | 2018-09-13 | 2018-09-13 | A kind of Chinese and Western compound preparation and preparation method thereof for treating senile dementia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811120481.4A CN108904739A (en) | 2018-09-13 | 2018-09-13 | A kind of Chinese and Western compound preparation and preparation method thereof for treating senile dementia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108904739A true CN108904739A (en) | 2018-11-30 |
Family
ID=64409109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811120481.4A Pending CN108904739A (en) | 2018-09-13 | 2018-09-13 | A kind of Chinese and Western compound preparation and preparation method thereof for treating senile dementia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108904739A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022007982A3 (en) * | 2020-07-10 | 2022-03-03 | 上海日馨医药科技股份有限公司 | Pharmaceutical composition and application thereof |
WO2023036105A1 (en) * | 2021-09-09 | 2023-03-16 | 上海日馨医药科技股份有限公司 | Method for treating neurodegenerative disease |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274013A (en) * | 2007-03-27 | 2008-10-01 | 高海 | Prescription medicine for curing senile dementia and preparation |
CN101954031A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating vascular dementia and preparation method |
CN107007700A (en) * | 2017-04-28 | 2017-08-04 | 珠海安生凤凰制药有限公司 | A kind of Chinese medicine composition promoting blood circulation and removing blood stasis and preparation method thereof |
CN107617040A (en) * | 2017-11-07 | 2018-01-23 | 余必亚 | A kind of pharmaceutical composition for treating senile dementia and preparation method thereof |
-
2018
- 2018-09-13 CN CN201811120481.4A patent/CN108904739A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274013A (en) * | 2007-03-27 | 2008-10-01 | 高海 | Prescription medicine for curing senile dementia and preparation |
CN101954031A (en) * | 2010-10-07 | 2011-01-26 | 山东省千佛山医院 | Medicament for treating vascular dementia and preparation method |
CN107007700A (en) * | 2017-04-28 | 2017-08-04 | 珠海安生凤凰制药有限公司 | A kind of Chinese medicine composition promoting blood circulation and removing blood stasis and preparation method thereof |
CN107617040A (en) * | 2017-11-07 | 2018-01-23 | 余必亚 | A kind of pharmaceutical composition for treating senile dementia and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
臧文举等: "补肾化痰益智方联合盐酸多奈哌齐片治疗阿尔茨海默病20例", 《中医研究》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022007982A3 (en) * | 2020-07-10 | 2022-03-03 | 上海日馨医药科技股份有限公司 | Pharmaceutical composition and application thereof |
EP4180040A4 (en) * | 2020-07-10 | 2024-02-28 | Shanghai Raising Pharmaceutical Co., Ltd. | Pharmaceutical composition and application thereof |
WO2023036105A1 (en) * | 2021-09-09 | 2023-03-16 | 上海日馨医药科技股份有限公司 | Method for treating neurodegenerative disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6305407B2 (en) | Chinese medicine composition for regulating immunity and method for producing the same | |
CN102038758B (en) | Rheumatism preparation used for treating rheumatism | |
CN1051237C (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
CN102161961B (en) | Health-care wine and preparation method thereof | |
CN108904739A (en) | A kind of Chinese and Western compound preparation and preparation method thereof for treating senile dementia | |
CN101537160B (en) | Health product for toxicant elimination and beauty maintenance | |
CN106310023A (en) | Drug for treating small cell lung cancer, and preparation method and application thereof | |
CN101912540A (en) | Medicament for treating cerebral infarction | |
CN109528807A (en) | A kind of Chinese medicine composition and its preparation method and application enhanced human immunity | |
CN104547619B (en) | It is a kind of to be used to treat Chinese medicine of apoplexy sequelae hemiplegia of limb and preparation method thereof | |
CN103908490A (en) | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof | |
CN101485716B (en) | Medicament for treating radiation injury and preparation method thereof | |
CN106138831A (en) | A kind of Chinese medicine composition treating cardiovascular and cerebrovascular disease and preparation method thereof | |
CN106421474A (en) | Formula for traditional Chinese medicines capable of lowering blood lipid | |
CN107648335B (en) | Traditional Chinese medicine composition for regulating atherosclerosis autophagy and apoptosis and preparation method thereof | |
CN102599501B (en) | Healthcare Hongyang capsule or tablet product for lowering lipid and protecting liver | |
CN104758578A (en) | Traditional Chinese medicine composition for treating palpitation | |
CN101549133B (en) | Ablation and embolism extinguishing preparation of Chinese medicine | |
CN109498803A (en) | The high Chinese medicine composition and preparation method thereof with cardiovascular disease for the treatment of three | |
CN103142696B (en) | Vessel-invigorating and life-prolonging soup and preparation method thereof | |
CN106983825A (en) | It is a kind of to be used to treat Chinese medicine composition of cerebral thrombus and its preparation method and application | |
CN102274428A (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
CN1116069C (en) | Health care oral liquid for old people and preparation process thereof | |
CN106421473A (en) | Preparation method of traditional Chinese medicine capable of reducing blood lipid | |
CN104547695B (en) | It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181130 |
|
RJ01 | Rejection of invention patent application after publication |